linical laboratory services provider Prodia Widyahusada started on Wednesday its first trading day as a publicly listed company on the Indonesia Stock Exchange (IDX), after cashing in Rp 1.22 trillion (US$91.4 million) from the sales of 20 percent of shares in its initial public offering (IPO).
Prodia finance director Lianda Kuswandi said the company would use 67 percent of the new funds to finance corporate expansion, including the opening of 33 new branches in the next four years, 19 percent to buy new equipment and the remaining 14 percent for working capital.
"The company is striving for healthy business growth under good [corporate] governance," she said at a press conference in the IDX building in Jakarta on Wednesday.
President director Dewi Muliaty, meanwhile, claimed that the company was currently the market leader in the industry, with 35 percent of the market share. By the first half of this year, the company’s revenue had increased 9.7 percent year-on-year (yoy) to Rp 648.6 billion and net profit had surged 22 percent yoy to Rp 32.1 billion, she said.
"Our market share is far ahead the second biggest [player] in the industry. We aim to keep this market share in the future," Dewi said.
The company currently runs 251 outlets in 104 Indonesian cities, with support 3,600 employees and 230 partner doctors. (hwa)
Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.
Thank you for sharing your thoughts. We appreciate your feedback.